RNA interference: implications for cancer treatment
- PMID: 17307250
- DOI: 10.1016/j.mam.2006.12.004
RNA interference: implications for cancer treatment
Abstract
RNA interference (RNAi) has emerged as one of the most important discoveries of the last years in the field of molecular biology. Following clarification of this highly conserved endogenous gene silencing mechanism, RNAi has largely been exploited as a powerful tool to uncover the function of specific genes and to understand the effects of selective gene silencing in mammalian cells both in vitro and in vivo. RNAi can be induced by direct introduction of chemically synthesized siRNAs into the cell or by the use of plasmid and viral vectors encoding for siRNA allowing a more stable RNA knockdown. Potential application of this technique both as a research tool and for therapeutic purposes has led to an extensive effort to overcome some critical constraints which may limit its successful application in vivo, including off-target and non-specific effects, as well as the relatively poor stability of siRNA. This review provides a brief overview of the RNAi mechanism and of its application in preclinical animal models of cancer.
Similar articles
-
RNA interference in pain research.J Neurochem. 2006 Oct;99(2):371-80. doi: 10.1111/j.1471-4159.2006.04082.x. J Neurochem. 2006. PMID: 17029593 Review.
-
RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research.Cancer Gene Ther. 2007 Aug;14(8):677-85. doi: 10.1038/sj.cgt.7701063. Epub 2007 Jun 1. Cancer Gene Ther. 2007. PMID: 17541422 Review.
-
[RNA interference: from origins to a novel tool for gene silencing].Rev Invest Clin. 2009 Sep-Oct;61(5):412-27. Rev Invest Clin. 2009. PMID: 20184102 Review. Spanish.
-
RNAi in functional genomics.Curr Opin Mol Ther. 2004 Apr;6(2):129-35. Curr Opin Mol Ther. 2004. PMID: 15195923 Review.
-
RNA interference and its current application in mammals.Chin Med J (Engl). 2004 Jul;117(7):1084-91. Chin Med J (Engl). 2004. PMID: 15265387 Review.
Cited by
-
Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth.Mol Ther. 2009 Feb;17(2):269-77. doi: 10.1038/mt.2008.266. Epub 2008 Dec 9. Mol Ther. 2009. PMID: 19066596 Free PMC article.
-
RNAi Screening of the Glucose-Regulated Chaperones in Cancer with Self-Assembled siRNA Nanostructures.Nano Lett. 2016 Oct 12;16(10):6099-6108. doi: 10.1021/acs.nanolett.6b02274. Epub 2016 Oct 3. Nano Lett. 2016. PMID: 27669096 Free PMC article.
-
pH-Responsive Polymer Nanomaterials for Tumor Therapy.Front Oncol. 2022 Mar 22;12:855019. doi: 10.3389/fonc.2022.855019. eCollection 2022. Front Oncol. 2022. PMID: 35392227 Free PMC article. Review.
-
Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.Clin Transl Oncol. 2023 May;25(5):1218-1241. doi: 10.1007/s12094-022-03050-z. Epub 2023 Mar 10. Clin Transl Oncol. 2023. PMID: 36897508 Review.
-
Is there a role for voltage-gated Na+ channels in the aggressiveness of breast cancer?Braz J Med Biol Res. 2017 Jun 5;50(7):e6011. doi: 10.1590/1414-431X20176011. Braz J Med Biol Res. 2017. PMID: 28591378 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources